Proliferating or interleukin 1-activated human vascular smooth muscle cells secrete copious interleukin 6.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Journal of Clinical Investigation

• Publication date

  1990-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI114498PMID 2312724PMCID PMC296489
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cytokines and endothelial cell biology.

  1990cited by this paper
• Detection of activated T lymphocytes in the human atherosclerotic plaque.

  1989cited by this paper
• Decay-accelerating factor is expressed on vascular smooth muscle cells in human atherosclerotic lesions.

  1989cited by this paper
• IL-1 stimulates IL-6 production in endothelial cells.

  1989cited by this paper
• Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells.

  1989cited by this paper
• Immune interferon inhibits proliferation and induces 2'-5'-oligoadenylate synthetase gene expression in human vascular smooth muscle cells.

  1989cited by this paper
• Regulation of Major Histocompatibility Gene Expression in Human Vascular Smooth Muscle Cells

  1989cited by this paper
• Human vascular smooth muscle cells. Target for and source of tumor necrosis factor.

  1989cited by this paper
• Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA.

  1989cited by this paper
• Adult human vascular endothelial cells express the IL6 gene differentially in response to LPS or IL1.

  1989cited by this paper
• Lymphocyte recruitment in delayed-type hypersensitivity. The role of IFN-gamma.

  1988cited by this paper
• Molecular regulation of B lymphocyte response.

  1988cited by this paper
• Cell cycle-dependent interleukin 1 gene expression by cultured glomerular mesangial cells.

  1988cited by this paper
• The pathogenesis of atherosclerosis: atherogenesis and inflammation.

  1988cited by this paper
• Angiocentric immunoproliferative lesions: a clinicopathologic spectrum of post-thymic T-cell proliferations.

  1988cited by this paper
• T lymphocytes in aortic and coronary intimas. Their potential role in atherogenesis.

  1988cited by this paper
• Expression of apolipoprotein E by cultured vascular smooth muscle cells is controlled by growth state

  1988cited by this paper
• Features of renal vasculitis in autoimmune MRL lpr/lpr mice: phenotypes and functional properties of infiltrating cells.

  1988cited by this paper
• HHF35, a muscle-actin-specific monoclonal antibody. I. Immunocytochemical and biochemical characterization.

  1987cited by this paper
• Structure and expression of human B cell stimulatory factor‐2 (BSF‐2/IL‐6) gene.

  1987cited by this paper
• Interleukin 1 induces interleukin 1. II. Recombinant human interleukin 1 induces interleukin 1 production by adult human vascular endothelial cells.

  1987cited by this paper
• Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells.

  1987cited by this paper
• Systemic mononuclear-cell vasculitis in MRL/Mp-lpr/lpr mice. A histologic and immunocytochemical analysis.

  1987cited by this paper
• Human interleukin 1 induces interleukin 1 gene expression in human vascular smooth muscle cells

  1987cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Induction and regulation of mRNA encoding 26-kDa protein in human cell lines treated with recombinant human tumor necrosis factor.

  1987cited by this paper
• Production of hybridoma growth factor by human monocytes

  1987cited by this paper
• Human beta 2 interferon and B-cell differentiation factor BSF-2 are identical.

  1987cited by this paper
• Characterization of a novel murine T cell-activating factor.

  1987cited by this paper
• Serum levels of interleukin-6 and acute phase responses.

  1987cited by this paper
• Acute inflammation and a Shwartzman-like reaction induced by interleukin-1 and tumor necrosis factor. Synergistic action of the cytokines in the induction of inflammation and microvascular injury.

  1987cited by this paper
• Structure and expression of cDNA and genes for human interferon‐beta‐2, a distinct species inducible by growth‐stimulatory cytokines.

  1986cited by this paper
• Anti-beta-interferon antibodies inhibit the increased expression of HLA-B7 mRNA in tumor necrosis factor-treated human fibroblasts: structural studies of the beta 2 interferon involved.

  1986cited by this paper
• Inducible interleukin-1 gene expression in human vascular smooth muscle cells.

  1986cited by this paper
• Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells.

  1986cited by this paper
• Induction of beta 2-interferon by tumor necrosis factor: a homeostatic mechanism in the control of cell proliferation.

  1986cited by this paper
• The pathogenesis of atherosclerosis--an update.

  1986cited by this paper
• Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitor

  1986cited by this paper
• Induction and detection of a human endothelial activation antigen in vivo

  1986cited by this paper
• Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin

  1986cited by this paper
• Regional Accumulations of T Cells, Macrophages, and Smooth Muscle Cells in the Human Atherosclerotic Plaque

  1986cited by this paper
• Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions.

  1986cited by this paper
• Interleukin 1 stimulates platelet activating factor production in cultured human endothelial cells.

  1986cited by this paper
• Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1

  1986cited by this paper
• Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1).

  1986cited by this paper
• Interleukin 1 stimulates platelet-activating factor production in cultured human endothelial cells.

  1986cited by this paper
• Platelet-derived growth factor and double-stranded ribonucleic acids stimulate expression of the same genes in 3T3 cells.

  1985cited by this paper
• Exaggerated human vascular cell prostaglandin biosynthesis mediated by monocytes: role of monokines and interleukin 1.

  1985cited by this paper
• Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis.

  1985cited by this paper
• Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines.

  1985cited by this paper
• Expression of I-region-associated antigen (Ia) and interleukin 1 by subcultured human endothelial cells.

  1985cited by this paper
• Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells

  1984cited by this paper
• Pulmonary vasculitis (Wegener's granulomatosis). Immunohistochemical study of T and B cell markers.

  1983cited by this paper
• Culture of quiescent arterial smooth muscle cells in a defined serum‐free medium

  1983cited by this paper
• HEPATOCYTE‐STIMULATING FACTOR: A MONOCYTE‐DERIVED ACUTE‐PHASE REGULATORY PROTEIN

  1983cited by this paper
• Secretory proteins induced in human fibroblasts under conditions used for the production of interferon beta.

  1982cited by this paper
• Phenotype-dependent response of cultured aortic smooth muscle to serum mitogens

  1981cited by this paper
• What controls smooth muscle phenotype?

  1981cited by this paper
• Two interferon mRNAs in human fibroblasts: in vitro translation and Escherichia coli cloning studies.

  1980cited by this paper
• Heterogeneity of poly(I).poly(C)-induced human fibroblast interferon mRNA species

  1980cited by this paper
• Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

  1979cited by this paper
• T cell growth factor: parameters of production and a quantitative microassay for activity.

  1978cited by this paper
• Proliferation

  1966cited by this paper

• Targeting inflammation in atherosclerosis: prospects and limitations

  2026cites this paper
• VSMCs in Atherosclerosis: Implications on the Role of Inflammation and Extracellular Matrix Remodelling.

  2025cites this paper
• Cardioprotective effects of carvacrol in the isoproterenol-induced myocardial infarction model

  2025influential citation
• Anti-inflammatory Therapies for Ischemic Heart Disease

  2025cites this paper
• Inflammation in atherosclerosis: Lessons and therapeutic implications.

  2025cites this paper
• Pathophysiological Mechanisms of Diabetes-Induced Macrovascular and Microvascular Complications: The Role of Oxidative Stress

  2025cites this paper
• Targeted Anti‐Inflammatory Therapy in Cardiovascular Events: Challenges and Opportunities

  2025cites this paper
• Ripple Effects of Early Life Stress on Vascular Health.

  2025cites this paper
• The Role of IL-6 in Ischemic Stroke

  2025cites this paper
• From Bench to Clinic: Advances in Anti‐Inflammatory Therapies for Atherosclerotic Coronary Artery Disease

  2025cites this paper
• Serum NLRP3: A potential marker for identifying high-risk coronary arterial aneurysm in children with Kawasaki disease.

  2024cites this paper
• Century of Milestones and Breakthroughs Related to the Immune Mechanisms of Atherosclerosis

  2024cites this paper
• The causal relationship between blood cell indices and 28-day mortality in sepsis: a retrospective study and bidirectional Mendelian randomization analysis

  2024cites this paper
• Myrtenol‐Loaded Fatty Acid Nanocarriers Protect Rat Brains Against Ischemia–Reperfusion Injury: Antioxidant and Anti‐Inflammatory Effects

  2024cites this paper
• The novel vaccines targeting interleukin-1 receptor type I.

  2024cites this paper
• Shared inflammatory pathways of rheumatoid arthritis and atherosclerotic cardiovascular disease

  2023cites this paper
• Interleukin-6 signaling in atherosclerosis: from molecular mechanisms to clinical outcomes.

  2023cites this paper
• SATB2, coordinated with CUX1, regulates IL‐1β‐induced senescence‐like phenotype in endothelial cells by fine‐tuning the atherosclerosis‐associated p16INK4a expression

  2023cites this paper
• Vascular smooth muscle cells in intimal hyperplasia, an update

  2023cites this paper
• Culprit plaque morphology determines inflammatory risk and clinical outcomes in acute coronary syndrome.

  2023cites this paper
• IL-6 helps weave the inflammatory web during acute coronary syndromes

  2023cites this paper
• Insights into the Role of Inflammation in the Management of Atherosclerosis

  2023cites this paper
• The Role of Oxidative Stress in Atherosclerosis

  2022cites this paper
• PDPN contributes to constructing immunosuppressive microenvironment in IDH wildtype glioma

  2022cites this paper
• Interleukin-6 Predicts Carotid Plaque Severity, Vulnerability, and Progression

  2022cites this paper
• Diabetes-Modifying Antirheumatic Drugs: The Roles of DMARDs as Glucose-Lowering Agents

  2022cites this paper
• Global research trends in atherosclerosis: A bibliometric and visualized study

  2022cites this paper
• Inflammatory Mediators in Atherosclerotic Vascular Remodeling

  2022cites this paper
• Analysis of differentially expressed genes and signaling pathways involved in atherosclerosis and chronic obstructive pulmonary disease

  2022cites this paper
• Tumor Necrosis Factor-α: The Next Marker of Stroke

  2022cites this paper
• Interleukin-1 in Coronary Artery Disease.

  2022cites this paper
• Antimicrobial and Anti-inflammatory Gallium-Defensin Surface Coatings for Implantable Devices.

  2022cites this paper
• Fibrotic Signaling in Cardiac Fibroblasts and Vascular Smooth Muscle Cells: The Dual Roles of Fibrosis in HFpEF and CAD

  2022cites this paper
• Clonal Hematopoiesis, Somatic Mosaicism, and Age-Associated Disease.

  2022cites this paper
• Atherosclerosis: The Involvement of Immunity, Cytokines and Cells in Pathogenesis, and Potential Novel Therapeutics

  2022cites this paper
• Interleukin-6 Signaling and Anti-Interleukin-6 Therapeutics in Cardiovascular Disease

  2021cites this paper
• Efficacy of Different Types of Therapy for COVID-19: A Comprehensive Review

  2021cites this paper
• Inhibition of Vascular Smooth Muscle and Cancer Cell Proliferation by New VEGFR Inhibitors and Their Immunomodulator Effect: Design, Synthesis, and Biological Evaluation

  2021cites this paper
• Role of Interleukin-6 in Vascular Health and Disease

  2021influential citation
• Preventive Effect and Mechanism of Crossostephium chinense Extract on Balloon Angioplasty-Induced Neointimal Hyperplasia

  2021cites this paper
• Interleukin-1 and the NLRP3 Inflammasome in Pericardial Disease

  2021cites this paper
• Smooth Muscle Cells

  2021cites this paper
• Targeting inflammation in atherosclerosis — from experimental insights to the clinic

  2021cites this paper
• IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial.

  2021cites this paper
• TNF‐α antagonism rescues the effect of ageing on stroke: Perspectives for targeting inflamm‐ageing

  2021cites this paper
• The potential role of Colchicine in preventing coronary vascular disease in childhood‐onset lupus: a new view on an old drug

  2021cites this paper
• Reversion inducing cysteine rich protein with Kazal motifs and cardiovascular diseases: The RECKlessness of adverse remodeling.

  2021cites this paper
• Immunotherapy in the Treatment of COVID-19

  2021cites this paper
• Cardiovascular Burden of COVID-19 and the Post-Covid Era

  2021cites this paper
• Inhibition of IL-6 in the LCWE Mouse Model of Kawasaki Disease Inhibits Acute Phase Reactant Serum Amyloid A but Fails to Attenuate Vasculitis

  2021cites this paper
• Beyond Lipoprotein(a) plasma measurements: Lipoprotein(a) and inflammation

  2021cites this paper
• ECHOCARDIOGRAPHIC MOLECULAR IMAGING OF THE EFFECT OF ANTI-CYTOKINE THERAPY FOR ATHEROSCLEROSIS.

  2020cites this paper
• Targeting IL-1β in the Treatment of Atherosclerosis

  2020cites this paper
• Role for Anti-Cytokine Therapies in Severe Coronavirus Disease 2019

  2020cites this paper
• Atherosclerotic Plaque Healing.

  2020cites this paper
• Interleukin-6 in acute coronary syndrome is a powerful predictor of long-term cardiovascular mortality.

  2020cites this paper
• Endothelial Damage, Inflammation and Immunity in Chronic Kidney Disease

  2020influential citation
• Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease

  2020cites this paper
• Cathelicidin Modulates Vascular Smooth Muscle Cell Phenotypic Switching through ROS/IL-6 Pathway

  2020cites this paper
• An outcome analysis of predictive factors for portal or splenic vein thrombosis after distal pancreatectomy

  2020cites this paper
• Inflammation in Atherosclerosis-No Longer a Theory.

  2020cites this paper
• Carotid intimal medial thickness in rotating night shift is related to IL1β/IL6 axis.

  2020cites this paper
• COVID-19 is, in the end, an endothelial disease

  2020cites this paper
• Anti-inflammatory therapy in atherosclerosis.

  2020cites this paper
• Interleukin-6 level is a powerful predictor of long-term cardiovascular mortality in patients with acute coronary syndrome

  2020cites this paper
• Specific NLRP3 Inhibition Protects Against Diabetes-Associated Atherosclerosis

  2020cites this paper
• The differential statin effect on cytokine production of monocytes or macrophages is mediated by differential geranylgeranylation-dependent Rac1 activation

  2019cites this paper
• NFkappaB is a Key Player in the Crosstalk between Inflammation and Cardiovascular Diseases

  2019cites this paper
• Carbohydrate-coated Gold-Silver nanoparticles for efficient elimination of multi drug resistant bacteria and in vivo wound healing.

  2019cites this paper
• Protective Actions of Oxytocin on Aortic Wistar and SHR VSMCs

  2019cites this paper
• Vascular Smooth Muscle Cell Plasticity and Autophagy in Dissecting Aortic Aneurysms

  2019cites this paper
• Crataegus Aronia protects and reverses vascular inflammation in a high fat diet rat model by an antioxidant mechanism and modulating serum levels of oxidized low-density lipoprotein

  2019influential citation
• Genetic Interleukin 6 Signaling Deficiency Attenuates Cardiovascular Risk in Clonal Hematopoiesis

  2019cites this paper
• Stage-dependent differential effects of interleukin-1 isoforms on experimental atherosclerosis.

  2019cites this paper
• Caspase-1 induces smooth muscle cell growth in hypoxia-induced pulmonary hypertension.

  2019cites this paper
• The Role of Platelets in Cancer Pathophysiology: Focus on Malignant Glioma

  2019cites this paper
• Angiotensin III Induces JAK2/STAT3 Leading to IL-6 Production in Rat Vascular Smooth Muscle Cells

  2019cites this paper
• Examining the Role of and Treatment Directed at IL-1β in Atherosclerosis

  2018cites this paper
• Promoter Usage and Dynamics in Vascular Smooth Muscle Cells Exposed to Fibroblast Growth Factor-2 or Interleukin-1β

  2018cites this paper
• All roads lead to IL-6: A central hub of cardiometabolic signaling.

  2018cites this paper
• Roles of platelet‐derived growth factor in vascular calcification

  2018cites this paper
• Myeloid cells as therapeutic targets in neuroinflammation after stroke: Specific roles of neutrophils and neutrophil–platelet interactions

  2018cites this paper
• Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS)

  2018cites this paper
• Interleukin-1β promotes atheroprotective changes of advanced atherosclerotic lesions in mice

  2018cites this paper
• Clonal Hematopoiesis: Somatic Mutations in Blood Cells and Atherosclerosis

  2018cites this paper
• Innate and adaptive immunity in atherosclerosis.

  2018cites this paper
• Atherosclerosis as an inflammatory disease: Doubts? No more

  2018cites this paper
• Immune regulation of systemic hypertension, pulmonary arterial hypertension, and preeclampsia: shared disease mechanisms and translational opportunities.

  2017cites this paper
• Cellular and Oxidative Mechanisms Associated with Interleukin-6 Signaling in the Vasculature

  2017cites this paper
• The immunology of atherosclerosis

  2017cites this paper
• New Insights into the Role of Inflammation in the Pathogenesis of Atherosclerosis

  2017cites this paper
• Inflammation and vascular smooth muscle cell dedifferentiation following carotid artery ligation.

  2017cites this paper
• Benzo[a]pyrene activates interleukin-6 induction and suppresses nitric oxide-induced apoptosis in rat vascular smooth muscle cells

  2017cites this paper
• Interleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and Beyond.

  2017cites this paper
• Cytokines in the perinatal period - Part I.

  2016cites this paper
• Cytokines in the perinatal period - Part II.

  2016cites this paper
• Angiotensin II induces interleukin-6 expression in astrocytes: Role of reactive oxygen species and NF-κB.

  2016cites this paper
• Acute Myocardial Infarction Early Interleukin-1 Receptor Antagonist Elevation in Patients With Acute Myocardial Infarction

  2016cites this paper
• IL-6 and MCP-1 production monocytes by soluble factors synergistically enhances Interaction of vascular smooth muscle cells and

  2016cites this paper
• Mimicking the Arterial Microenvironment with PEG-PC to Investigate the Roles of Physicochemical Stimuli in SMC Phenotype and Behavior

  2015cites this paper